The closing price of Quince Therapeutics Inc (NASDAQ: QNCX) was $1.06 for the day, down -6.19% from the previous closing price of $1.13. In other words, the price has decreased by -$0.0700 from its previous closing price. On the day, 51794 shares were traded.
Ratios:
Our analysis of QNCX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 37.80 and its Current Ratio is at 37.80. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 14 ’23 when Lamond David bought 22,627 shares for $1.04 per share. The transaction valued at 23,532 led to the insider holds 2,347,545 shares of the business.
Lamond David bought 22,627 shares of QNCX for $22,627 on Dec 13 ’23. The Director now owns 2,324,918 shares after completing the transaction at $1.00 per share. On Dec 12 ’23, another insider, Lamond David, who serves as the Director of the company, bought 22,327 shares for $1.02 each. As a result, the insider paid 22,774 and bolstered with 2,302,291 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QNCX now has a Market Capitalization of 45.44M and an Enterprise Value of -37.72M.
Stock Price History:
Over the past 52 weeks, QNCX has reached a high of $1.93, while it has fallen to a 52-week low of $0.84. The 50-Day Moving Average of the stock is 1.2556, while the 200-Day Moving Average is calculated to be 1.2056.
Shares Statistics:
QNCX traded an average of 70.98K shares per day over the past three months and 36.69k shares per day over the past ten days. A total of 36.14M shares are outstanding, with a floating share count of 29.70M. Insiders hold about 30.72% of the company’s shares, while institutions hold 16.92% stake in the company. Shares short for QNCX as of Mar 15, 2024 were 1.86M with a Short Ratio of 26.25, compared to 1.9M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.35% and a Short% of Float of 5.15%.
Earnings Estimates
The firm’s stock currently is rated by 0 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.78. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
